Author: Andrew Page

Strong sales growth for Polynovo (ASX:PNV) underpins share price gains

Shares in med-tech developer Polynovo (ASX:PNV) have doubled in the past year, driven by surging sales in its patented Novosorb product. More recently, the company revealed its first “million dollar month”, with sales for April ostensibly bringing the business to break-even on a monthly basis. What does the business do? Following a business restructure in 2014, Polynovo is focused on […]

Episode 22: Season finale! Vista Group and reminiscences of a glorious raging bull market

In this, our finale episode for the season, Claude takes us through the investment case for Vista Group (VGL), and we reminisce about past episodes and stock picks. For more great content, please visit us at www.strawman.com, www.mattjoass.com & www.ethicalequities.com.au Email us at threewisemonkeyspodcast@gmail.com And find us on Twitter @sage_simian @mattjoass @claudedwalker Return to the Strawman Platform here Strawman is Australia’s premier online investment club. Join for […]

Episode 21: MicroCap Conference recap

This week, we attended the inaugural Coffee Microcaps conference, where we had the chance to hear from a bunch of interesting Micro-cap companies, as well as rub shoulders with some heavy-hitting private & professional investors. We run through our thoughts on all the companies that presented: Volpara (VHT), BlackWall (BWF), SkyFi (SKF), Kangaroo Plantation Timber (KPT), Locality Planning (LPE), XRef […]